Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03769493 · ClinicalTrials.gov registry record · NA
Mobile After-Care Intervention to Support Post-Hospital Transition (MACS)
A NA study of Psychotic Disorders, sponsored by Butler Hospital.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT03769493: Completed NA study of Psychotic Disorders, sponsored by Butler Hospital.
NCT03769493 is a NA study of Psychotic Disorders that has completed, run by Butler Hospital. The registered enrollment target is 10 participants, below the 255-participant average among 22 other Psychotic Disorders trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03769493, a NA study of Psychotic Disorders, has completed, sponsored by Butler Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
This study examines the feasibility and acceptability of a mobile device-delivered app, called Mobile After-Care Support (MACS), to improve patients' coping and treatment adherence following a hospitalization related to their psychotic-spectrum disorder.
Primary Outcome
The Client Satisfaction Questionnaire is a self-report measure of patient satisfaction with treatment. The total score will be used and ranges from 8 to 32 with increased scores indicating greater satisfaction with treatment.
Conditions Studied
Interventions
- BEHAVIORAL Mobile After-Care Support (MACS) app
Study Locations (1)
Rhode Island
- Butler Hospital - Providence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2019-01-16 |
| Est. Completion | 2019-10-15 |
| Phase | NA |
What the finished NCT03769493 record still lists
NCT03769493 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 255-participant average among 22 other Psychotic Disorders trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Psychotic Disorders appearing as the primary indexed condition, and to 1 intervention - of which Mobile After-Care Support (MACS) app is the first listed.
NCT03769493 reports a single indexed study location in Rhode Island.
Frequently Asked Questions
What is clinical trial NCT03769493 about?
NCT03769493 is a clinical study titled "Mobile After-Care Intervention to Support Post-Hospital Transition (MACS)". This study examines the feasibility and acceptability of a mobile device-delivered app, called Mobile After-Care Support (MACS), to improve patients' coping and treatment adherence following a hospitalization related to their psychotic-spectrum disorder.
What is the current status of trial NCT03769493?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2019-01-16. Estimated completion is 2019-10-15.
What conditions does trial NCT03769493 study?
This clinical trial studies the following conditions: Psychotic Disorders.
What interventions are being tested in trial NCT03769493?
The interventions under investigation include: Mobile After-Care Support (MACS) app (BEHAVIORAL).
Who is sponsoring clinical trial NCT03769493?
This trial is sponsored by Butler Hospital, which has 103 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03769493 being conducted?
This trial has 1 study location across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Psychotic Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03769493's enrollment target sits among peer trials
10 22nd of 22 higher than 1 of 22 other Psychotic Disorders trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Psychotic Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Development of a Transdiagnostic Intervention for Adolescents at Risk for Serious Mental Illness
RECRUITING · NA
-
A Preventive Behavioral Intervention for Young Adults With Psychotic Experiences
RECRUITING · NA
-
Racial Disparities in the Expression of Paranoia
RECRUITING · NA
-
Clinical Study Evaluating Pharmacogenomics-informed Pharmacotherapy Versus Dosing as Usual in Psychiatric Disorders
RECRUITING · NA
-
A Novel Peer-Delivered Recovery-Focused Suicide Prevention Intervention for Veterans With Serious Mental Illness
RECRUITING · NA
-
CBT-CP for Veterans With SMI
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI